Krystal, John H.

NMDA receptor function in large-scale anticorrelated neural systems with implications for cognition and schizophrenia

Anticevic, A., Gancsos, M., Murray, J. D., Repovs, G., Driesen, N. R., Ennis, D. J., Niciu, M. J., Morgan, P. T., Surti, T. S., Bloch, M. H., et al. (2012) · Proceedings of the National Academy of Sciences

Functional Brain Connectivity StudiesNeuroscience and Neuropharmacology Research

Cited by 243

Capturing the Angel in "Angel Dust": Twenty Years of Translational Neuroscience Studies of NMDA Receptor Antagonists in Animals and Humans

Moghaddam, B., & Krystal, J. H. (2012) · Schizophrenia Bulletin

Schizophrenia research and treatmentNeuroscience and Neuropharmacology Research

Cited by 238

Frontostriatal Abnormalities in Adolescents With Bipolar Disorder: Preliminary Observations From Functional MRI

Blumberg, H. P., Martin, A., Kaufman, J., Leung, H.-C., Skudlarski, P., Lacadie, C., Fulbright, R. K., Gore, J. C., Charney, D. S., Krystal, J. H., et al. (2003) · American Journal of Psychiatry

Bipolar Disorder and TreatmentSchizophrenia research and treatment

Cited by 235

Glutamatergic model psychoses: prediction error, learning, and inference

Corlett, P. R., Honey, G. D., Krystal, J. H., & Fletcher, P. C. (2011) · Neuropsychopharmacology

Schizophrenia research and treatmentPsychedelics and Drug Studies

Cited by 229

The effects of ketamine on prefrontal glutamate neurotransmission in healthy and depressed subjects

Abdallah, C. G., De Feyter, H. M., Averill, L. A., Jiang, L., Averill, C. L., Chowdhury, G. M. I., Purohit, P., de Graaf, R. A., Esterlis, I., Juchem, C., et al. (2018) · Neuropsychopharmacology

Treatment of Major DepressionNeuroscience and Neuropharmacology Research

Cited by 229

Relationship of resting brain hyperconnectivity and schizophrenia-like symptoms produced by the NMDA receptor antagonist ketamine in humans

Driesen, N. R., McCarthy, G., Bhagwagar, Z., Bloch, M., Calhoun, V, D'Souza, D. C., Gueorguieva, R., He, G., Ramachandran, R., Suckow, R. F., et al. (2013) · Molecular Psychiatry

Schizophrenia research and treatmentFunctional Brain Connectivity Studies

Cited by 224

Sex differences in striatal dopamine release in young adults after oral alcohol challenge: a positron emission tomography imaging study with [11C]raclopride

Urban, N. B. L., Kegeles, L. S., Slifstein, M., Xu, X., Martinez, D., Sakr, E., Castillo, F., Moadel, T., O'Malley, S. S., Krystal, J. H., et al. (2010) · Biological Psychiatry

Neurotransmitter Receptor Influence on BehaviorSubstance Abuse Treatment and Outcomes

Cited by 223

The neurobiology of depression, ketamine and rapid-acting antidepressants: Is it glutamate inhibition or activation?

Abdallah, C. G., Sanacora, G., Duman, R. S., & Krystal, J. H. (2018) · Pharmacology & Therapeutics

Treatment of Major DepressionNeuroscience and Neuropharmacology Research

Cited by 219

Genetic and Environmental Predictors of Early Alcohol Use

Kaufman, J., Yang, B.-Z., Douglas-Palumberi, H., Crouse-Artus, M., Lipschitz, D., Krystal, J. H., & Gelernter, J. (2007) · Biological Psychiatry

Child Abuse and TraumaSubstance Abuse Treatment and Outcomes

Cited by 216

Medication compliance feedback and monitoring in a clinical trial: predictors and outcomes

Cramer, J., Rosenheck, R., Kirk, G., Krol, W., & Krystal, J. (2003) · Value in Health

Medication Adherence and ComplianceSubstance Abuse Treatment and Outcomes

Cited by 212

The NMDA Antagonist Model for Schizophrenia: Promise and Pitfalls

Abi-Saab, W., D'Souza, D., Moghaddam, B., & Krystal, J. (1998) · Pharmacopsychiatry

Schizophrenia research and treatmentNeurotransmitter Receptor Influence on Behavior

Cited by 208

KETAMINE'S MECHANISM OF ACTION: A PATH TO RAPID‐ACTING ANTIDEPRESSANTS

Abdallah, C. G., Adams, T. G., Kelmendi, B., Esterlis, I., Sanacora, G., & Krystal, J. H. (2016) · Depression and Anxiety

Treatment of Major DepressionElectroconvulsive Therapy Studies

Cited by 206

Corpus callosum in maltreated children with posttraumatic stress disorder: A diffusion tensor imaging study

Jackowski, A. P., Douglas-Palumberi, H., Jackowski, M., Win, L., Schultz, R. T., Staib, L. W., Krystal, J. H., & Kaufman, J. (2008) · Psychiatry Research: Neuroimaging

Child Abuse and TraumaPosttraumatic Stress Disorder Research

Cited by 206

Glutamate Metabolism in Major Depressive Disorder

Abdallah, C. G., Jiang, L., De Feyter, H. M., Fasula, M., Krystal, J. H., Rothman, D. L., Mason, G. F., & Sanacora, G. (2014) · American Journal of Psychiatry

Treatment of Major DepressionNeuroscience and Neuropharmacology Research

Cited by 200

Glutamatergic targets for new alcohol medications

Holmes, A., Spanagel, R., & Krystal, J. H. (2013) · Psychopharmacology

Neuroscience and Neuropharmacology ResearchNeurotransmitter Receptor Influence on Behavior

Cited by 197

MAOA Genotype, Maltreatment, and Aggressive Behavior: The Changing Impact of Genotype at Varying Levels of Trauma

Weder, N., Yang, B. Z., Douglas-Palumberi, H., Massey, J., Krystal, J. H., Gelernter, J., & Kaufman, J. (2009) · Biological Psychiatry

Child Abuse and TraumaNeurotransmitter Receptor Influence on Behavior

Cited by 190

Default mode network abnormalities in posttraumatic stress disorder: A novel network-restricted topology approach

Akiki, T. J., Averill, C. L., Wrocklage, K. M., Scott, J. C., Averill, L. A., Schweinsburg, B., Alexander-Bloch, A., Martini, B., Southwick, S. M., Krystal, J. H., et al. (2018) · NeuroImage

Functional Brain Connectivity StudiesPosttraumatic Stress Disorder Research

Cited by 188

Modulation of the antidepressant effects of ketamine by the mTORC1 inhibitor rapamycin

Abdallah, C. G., Averill, L. A., Gueorguieva, R., Goktas, S., Purohit, P., Ranganathan, M., Sherif, M., Ahn, K.-H., D’Souza, D. C., Formica, R., et al. (2020) · Neuropsychopharmacology

Treatment of Major DepressionElectroconvulsive Therapy Studies

Cited by 184

Individuals Family History Positive for Alcoholism Show Functional Magnetic Resonance Imaging Differences in Reward Sensitivity That Are Related to Impulsivity Factors

Andrews, M. M., Meda, S. A., Thomas, A. D., Potenza, M. N., Krystal, J. H., Worhunsky, P., Stevens, M. C., O'Malley, S., Book, G. A., Reynolds, B., et al. (2011) · Biological Psychiatry

Neurotransmitter Receptor Influence on BehaviorNeural and Behavioral Psychology Studies

Cited by 181

N-Methyl-D-Aspartate Receptor Antagonist Effects on Prefrontal Cortical Connectivity Better Model Early Than Chronic Schizophrenia

Anticevic, A., Corlett, P. R., Cole, M. W., Savic, A., Gancsos, M., Tang, Y., Repovs, G., Murray, J. D., Driesen, N. R., Morgan, P. T., et al. (2015) · Biological Psychiatry

Schizophrenia research and treatmentFunctional Brain Connectivity Studies

Cited by 181

Potential Psychiatric Applications of Metabotropic Glutamate Receptor Agonists and Antagonists

Krystal, J. H., Mathew, S. J., DʼSouza, D. C., Garakani, A., Gunduz-Bruce, H., & Charney, D. S. (2010) · CNS Drugs

Neuroscience and Neuropharmacology ResearchTreatment of Major Depression

Cited by 180

Early-course unmedicated schizophrenia patients exhibit elevated prefrontal connectivity associated with longitudinal change

Anticevic, A., Hu, X., Xiao, Y., Hu, J., Li, F., Bi, F., Cole, M. W., Savic, A., Yang, G. J., Repovs, G., et al. (2015) · The Journal of Neuroscience

Functional Brain Connectivity StudiesSchizophrenia research and treatment

Cited by 178

Riluzole in the Treatment of Mood and Anxiety Disorders

Pittenger, C., Coric, V., Banasr, M., Bloch, M., Krystal, J. H., & Sanacora, G. (2008) · CNS Drugs

Treatment of Major DepressionNeuroscience and Neuropharmacology Research

Cited by 177

Age, Rapid-Cycling, and Pharmacotherapy Effects on Ventral Prefrontal Cortex in Bipolar Disorder: A Cross-Sectional Study

Blumberg, H. P., Krystal, J. H., Bansal, R., Martin, A., Dziura, J., Durkin, K., Martin, L., Gerard, E., Charney, D. S., & Peterson, B. S. (2006) · Biological Psychiatry

Bipolar Disorder and TreatmentSchizophrenia research and treatment

Cited by 171